Old Web
English
Sign In
Acemap
>
authorDetail
>
Bjørn Sperling
Bjørn Sperling
Interferon beta-1a
Pharmacology
Medicine
Biosimilar
Immunogenicity
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Low immunogenicity but reduced bioavailability of an interferon beta-1a biosimilar compared with its biological parent: results of MATRIX, a cross-sectional, multicenter phase 4 study
2015
Carlos Cuevas
Florian Deisenhammer
Xiaojun You
Mariano Scolnik
Regine Buffels
Bjørn Sperling
Francisco Flores-Ramírez
Miguel Macias-Islas
Sergio Sauri Suárez
Show All
Source
Cite
Save
Citations (3)
Large Eddy Simulationen von selbstgravitierenden Akkretionsscheiben
2013
Bjørn Sperling
Show All
Source
Cite
Save
Citations (0)
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
2012
Therapeutics and Clinical Risk Management
Gary Bloomgren
Bjørn Sperling
Kimberly Cushing
Madé Wenten
Show All
Source
Cite
Save
Citations (13)
1